IMARA Inc. – NASDAQ:IMRA
IMARA stock price today
$37.96
+31.64
+500.63%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 1 day
IMARA stock price monthly change
+48.71%
month
IMARA stock price quarterly change
+41.70%
quarter
IMARA stock price yearly change
+335.86%
year
IMARA key metrics
Market Cap | 165.79M |
Enterprise value | N/A |
P/E | 105.33 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | 0.46 |
PEG ratio | 1.02 |
EPS | N/A |
Revenue | N/A |
EBITDA | -64.05M |
Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeIMARA stock price history
IMARA stock forecast
IMARA financial statements
| Dec 2022 | 0 | 32.27M | |
|---|---|---|---|
| Mar 2023 | 0 | 0 | |
| Jun 2023 | 0 | -16.72M | |
| Sep 2023 | 0 | -20.76M |
| Dec 2022 | 91959000 | 1.83M | 1.99% |
|---|---|---|---|
| Mar 2023 | 302866000 | 11.45M | 3.78% |
| Jun 2023 | 288501000 | 9.50M | 3.3% |
| Sep 2023 | 274041000 | 12.29M | 4.49% |
| Dec 2022 | -1.88M | 41.82M | -1.23M |
|---|---|---|---|
| Mar 2023 | -20.84M | -31K | 237.44M |
| Jun 2023 | 4.19M | 0 | 0 |
| Sep 2023 | 0 | 0 | 0 |
IMARA alternative data
| Aug 2023 | 41 |
|---|---|
| Sep 2023 | 41 |
| Oct 2023 | 41 |
| Nov 2023 | 41 |
| Dec 2023 | 41 |
| Jan 2024 | 41 |
| Feb 2024 | 41 |
| Mar 2024 | 41 |
| Apr 2024 | 41 |
| May 2024 | 41 |
| Jun 2024 | 41 |
| Jul 2024 | 41 |
IMARA other data
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Feb 2023 | 24186 | 42717 |
| Aug 2023 | 0 | 440000 |
| Sep 2023 | 0 | 221500 |
| Nov 2023 | 0 | 16572 |
| Dec 2023 | 0 | 55166 |
| Jan 2024 | 0 | 20383 |
| Patent |
|---|
Application Filling date: 29 Oct 2021 Issue date: 17 Feb 2022 |
Application Filling date: 4 Oct 2021 Issue date: 27 Jan 2022 |
Application TREATMENT OF PULMONARY ARTERIAL HYPERTENSION USING THERAPEUTICALLY EFFECTIVE ORAL DOSES OF 10-NITRO-9(E)-OCTADEC-9-ENOIC ACID Filling date: 19 Mar 2021 Issue date: 6 Jan 2022 |
Application Filling date: 26 Feb 2021 Issue date: 17 Jun 2021 |
Application MONOHYDRATE AND CRYSTALLINE FORMS OF 6-[(3S,4S)-4-METHYL-1-(PYRIMIDIN-2-YLMETHYL)PYRROLIDIN-3-YL]-3-TETRAHYDRO- PYRAN-4-YL-7H-IMIDAZO[1,5-A]PYRAZIN-8-ONE Filling date: 2 Dec 2020 Issue date: 15 Apr 2021 |
Application Filling date: 9 Oct 2020 Issue date: 25 Mar 2021 |
Application Filling date: 25 May 2018 Issue date: 21 May 2020 |
Application Filling date: 30 Jun 2017 Issue date: 10 Oct 2019 |
| Quarter | Transcript |
|---|---|
| Q4 2021 15 Mar 2022 | Q4 2021 Earnings Call Transcript |
| Q3 2021 9 Nov 2021 | Q3 2021 Earnings Call Transcript |
| Q2 2021 8 Aug 2021 | Q2 2021 Earnings Call Transcript |
| Q1 2021 11 May 2021 | Q1 2021 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Dr. Rahul D. Ballal Ph.D. (1978) Pres, Chief Executive Officer & Director | $617,660 |
Mr. Michael P. Gray MBA, CPA (1971) Chief Financial Officer & Chief Operating Officer | $530,330 |
-
What's the price of IMARA stock today?
One share of IMARA stock can currently be purchased for approximately $37.96.
-
When is IMARA's next earnings date?
Unfortunately, IMARA's (IMRA) next earnings date is currently unknown.
-
Does IMARA pay dividends?
No, IMARA does not pay dividends.
-
How much money does IMARA make?
IMARA has a market capitalization of 165.79M.
-
What is IMARA's stock symbol?
IMARA Inc. is traded on the NASDAQ under the ticker symbol "IMRA".
-
What is IMARA's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of IMARA?
Shares of IMARA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are IMARA's key executives?
IMARA's management team includes the following people:
- Dr. Rahul D. Ballal Ph.D. Pres, Chief Executive Officer & Director(age: 47, pay: $617,660)
- Mr. Michael P. Gray MBA, CPA Chief Financial Officer & Chief Operating Officer(age: 54, pay: $530,330)
-
How many employees does IMARA have?
As Jul 2024, IMARA employs 41 workers.
-
When IMARA went public?
IMARA Inc. is publicly traded company for more then 5 years since IPO on 12 Mar 2020.
-
What is IMARA's official website?
The official website for IMARA is imaratx.com.
-
Where are IMARA's headquarters?
IMARA is headquartered at 116 Huntington Avenue, Boston, MA.
-
How can i contact IMARA?
IMARA's mailing address is 116 Huntington Avenue, Boston, MA and company can be reached via phone at +61 72062020.
IMARA company profile:
IMARA Inc.
imaratx.comExchange:
NASDAQ
Full time employees:
41
Industry:
Biotechnology
Sector:
Healthcare
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas. IMARA Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
116 Huntington Avenue
Boston, MA 02116
Boston, MA 02116
CIK: 0001672619
ISIN: US45249V1070
CUSIP: 45249V107
